Mitchell C. Posner

11.2k total citations · 1 hit paper
175 papers, 6.4k citations indexed

About

Mitchell C. Posner is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitchell C. Posner has authored 175 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 68 papers in Surgery and 65 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitchell C. Posner's work include Pancreatic and Hepatic Oncology Research (35 papers), Gastric Cancer Management and Outcomes (29 papers) and Esophageal Cancer Research and Treatment (29 papers). Mitchell C. Posner is often cited by papers focused on Pancreatic and Hepatic Oncology Research (35 papers), Gastric Cancer Management and Outcomes (29 papers) and Esophageal Cancer Research and Treatment (29 papers). Mitchell C. Posner collaborates with scholars based in United States, Canada and United Kingdom. Mitchell C. Posner's co-authors include Ralph R. Weichselbaum, Peter Wu, Nikolai N. Khodarev, Peter W. T. Pisters, Mark K. Ferguson, Thomas E. Darga, John Hart, Helena J. Mauceri, Vivek N. Prachand and Samuel Hellmän and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Mitchell C. Posner

171 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic

2020 228 citations Ross Milner, Peter Angelos et al. profile →

Peers

Countries citing papers authored by Mitchell C. Posner

Since Specialization

Citations

This map shows the geographic impact of Mitchell C. Posner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell C. Posner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell C. Posner more than expected).

Fields of papers citing papers by Mitchell C. Posner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell C. Posner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell C. Posner. The network helps show where Mitchell C. Posner may publish in the future.

Co-authorship network of co-authors of Mitchell C. Posner

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell C. Posner. A scholar is included among the top collaborators of Mitchell C. Posner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell C. Posner. Mitchell C. Posner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy 2022 ·npj Precision Oncology ·Liam F. Spurr, Carlos A. Martinez, Rohan Katipally, Soumya Iyer, S. Pugh, John Bridgewater, John Primrose, Enric Domingo, Tim Maughan, Michael I. D’Angelica, Mark S. Talamonti, Mitchell C. Posner, Philip P. Connell, Ralph R. Weichselbaum, Sean P. Pitroda	5
2	Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? 2020 ·Surgery ·Ross Milner, Jessica Donington, Jeffrey B. Matthews, Mitchell C. Posner, Kiran K. Turaga, Peter Angelos	4
3	A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses 2020 ·Journal of Gastrointestinal Oncology ·Stanley L. Liauw, (unknown), Tianming Wu, (unknown), Denise Cloutier, Mitchell C. Posner, Mark Kozloff, Hedy L. Kindler	9
4	Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases 2019 ·Cancer ·Abhineet Uppal, Fabrice Smieliauskas, (unknown), Steven B. Maron, Blasé N. Polite, Mitchell C. Posner, Kiran K. Turaga	12
5	Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance) 2019 ·Annals of Surgical Oncology ·Waddah B. Al‐Refaie, Paul A. Decker, Karla V. Ballman, Peter W. T. Pisters, Mitchell C. Posner, Kelly K. Hunt, Bryan F. Meyers, Armin D. Weinberg, Heidi Nelson, Lisa A. Newman, Angelina D. Tan, Jennifer Le‐Rademacher, Arti Hurria, Aminah Jatoi	2
6	Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial 2019 ·Annals of Surgical Oncology ·Alice C. Wei, Fang‐Shu Ou, Qian Shi, Xiomara W. Carrero, Eileen M. O’Reilly, Jeffrey A. Meyerhardt, Robert A. Wolff, Hedy L. Kindler, Douglas B. Evans, Vikram Deshpande, Joseph Misdraji, Eric P. Tamm, Dushyant V. Sahani, Malcolm J. Moore, Elliot Newman, Nipun B. Merchant, Jordan Berlin, Laura W. Goff, Peter W. T. Pisters, Mitchell C. Posner	19
7	DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs 2018 ·Cancer Research ·Go Oshima, (unknown), Michael J. Bolt, Alexandre Chlenski, (unknown), Jessica M.S. Jutzy, Neha Biyani, Mitchell C. Posner, Sean P. Pitroda, Ralph R. Weichselbaum, Nikolai N. Khodarev	39
8	JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers 2018 ·Molecular Cancer Therapeutics ·Sean P. Pitroda, Melinda E. Stack, (unknown), (unknown), Lucy Chen, Hua Liang, Akash D. Parekh, Xiaona Huang, Paul D. Roach, Mitchell C. Posner, Ralph R. Weichselbaum, Nikolai N. Khodarev	20
9	Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study 2017 ·Journal of Surgical Oncology ·Robert Marsh, Marina Talamonti, Marshall S. Baker, Mitchell C. Posner, Kevin K. Roggin, Jeffrey B. Matthews, Daniel V.T. Catenacci, Mark Kozloff, Blasé N. Polite, (unknown), Chi Wang, Hedy L. Kindler	26
10	Transhiatal Esophagectomy for Esophageal Cancer 2016 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Jukes P. Namm, Mitchell C. Posner	2
11	Complete Endoscopic Mucosal Resection Is Effective and Durable Treatment for Barrett's-Associated Neoplasia 2014 ·Clinical Gastroenterology and Hepatology ·Vani J. Konda, Mariano González-Haba, Ann Koons, John Hart, Shu-Yuan Xiao, Uzma D. Siddiqui, Mark K. Ferguson, Mitchell C. Posner, Marco G. Patti, Irving Waxman	51
12	Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs 2013 ·PLoS ONE ·Yves A. Lussier, Nikolai N. Khodarev, Kelly Regan, Kimberly S. Corbin, Haiquan Li, Sabha Ganai, Sajid Khan, Jennifer L. Gnerlich, Thomas E. Darga, Hanli Fan, (unknown), Philip B. Paty, Mitchell C. Posner, Steven J. Chmura, Samuel Hellmän, Mark K. Ferguson, Ralph R. Weichselbaum	0
13	Geriatric Assessment Improves Prediction of Surgical Outcomes in Older Adults Undergoing Pancreaticoduodenectomy 2013 ·Annals of Surgery ·William Dale, Joshua Hemmerich, (unknown), Mitchell C. Posner, Jeffrey B. Matthews, (unknown), (unknown), Kevin K. Roggin	116
14	Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation 2005 ·Cancer Research ·(unknown), Mitchell C. Posner, James O. Park, Thomas E. Darga, Masha Kocherginsky, Theodore Karrison, John Hart, Kerrington D. Smith, James J. Mezhir, Ralph R. Weichselbaum, Nikolai N. Khodarev	133
15	Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era 2003 ·Surgery ·Peter Wu, Alexander Langerman, Christopher W. Ryan, John Hart, (unknown), Mitchell C. Posner	93
16	Transcriptional control of viral gene therapy by cisplatin 2002 ·Journal of Clinical Investigation ·James O. Park, Carlos López, Vinay Gupta, Charles K. Brown, Helena J. Mauceri, Thomas E. Darga, (unknown), Samuel Hellmän, Mitchell C. Posner, Donald Küfe, Ralph R. Weichselbaum	36
17	Transcriptional control of viral gene therapy by cisplatin 2002 ·Journal of Clinical Investigation ·James O. Park, Carlos López‐Jaramillo, Vinay Gupta, (unknown), Helena J. Mauceri, Thomas E. Darga, (unknown), Samuel Hellmän, Mitchell C. Posner, Donald Küfe, Ralph R. Weichselbaum	1
18	Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma 2002 ·Annals of Surgical Oncology ·(unknown), James O. Park, (unknown), Helena J. Mauceri, Saraswathy Seetharam, Ralph R. Weichselbaum, Mitchell C. Posner	26
19	Profiting from Emerging Market Stocks 1998 ·Scandinavian Journal of Rheumatology ·Mitchell C. Posner	5
20	Metabolic Alterations in Obstructive Jaundice: Effect of Duration of Jaundice and Bile‐Duct Decompression 1991 ·HPB Surgery ·(unknown), N. Vydelingum, (unknown), Francesca Scognamiglio, Luís Eduardo Coelho Andrade, Mitchell C. Posner, Murray F. Brennan	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact